Yixintang Pharmaceutical Group Co (SZSE:002727) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Yixintang Pharmaceutical Group Co Other Net Income (Loss)?

Yixintang Pharmaceutical Group Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0 Mil.

Yixintang Pharmaceutical Group Co's quarterly Other Net Income (Loss) declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥-0 Mil) but then increased from Dec. 2023 (¥-0 Mil) to Mar. 2024 (¥0 Mil).

Yixintang Pharmaceutical Group Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥-0 Mil) but then increased from Dec. 2022 (¥-0 Mil) to Dec. 2023 (¥0 Mil).

Yixintang Pharmaceutical Group Co Other Net Income (Loss) Historical Data

The historical data trend for Yixintang Pharmaceutical Group Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yixintang Pharmaceutical Group Co Other Net Income (Loss) Chart

Yixintang Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Yixintang Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Yixintang Pharmaceutical Group Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Yixintang Pharmaceutical Group Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Yixintang Pharmaceutical Group Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Yixintang Pharmaceutical Group Co (SZSE:002727) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yixintang Pharmaceutical Group Co Ltd (SZSE:002727) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

No. 1 Hongxiang Road, Economic Development Zone, Yunnan province, Kunming City, CHN, 650500

Website

http://www.hx8886.com

Yixintang Pharmaceutical Group Co Ltd is a China-based company engages in the operation of pharmaceutical retail chains and wholesale businesses. Its products include traditional Chinese medicine, Western medicine, and medical equipment.

Executives

Zhang Yong	Directors, executives
Xiao Dong Lei	Executives
Liu Qiong	Director
Ruan Hong Xian	Directors, executives
Guo Chun Li	Director
Ruan Guo Wei	Directors, executives
Li Zheng Hong	Directors, executives
Zhao Biao	Directors, executives
Tian Jun	Directors, Directors, and Executives
Xu Ke Yi	Director
Luo Yong Bin	Executives
Zhou Hong Yun	Directors, executives

Yixintang Pharmaceutical Group Co (SZSE:002727) Headlines

No Headlines